| Cholesterol: |
| Alternative to Statins Shows Promise (HealthDay) |
| HealthDay - WEDNESDAY, March 10 (HealthDay News) -- A thyroid-derived
cholesterol-lowering drug that could be an alternative to the widely used
statin medications has done well in a small, early trial, Swedish and
American researchers report. |
| Doctors fail to cut cholesterol enough (Reuters) |
| Reuters - Only half of patients at high risk of heart disease are given the right targets for cutting their cholesterol and millions may suffer heart attack or stroke due to doctors' poor advice, scientists said on Thursday. |
| Teamwork Unlikely to Improve Cholesterol Levels (HealthDay) |
| HealthDay - MONDAY, March 8 (HealthDay News) -- For patients with high
cholesterol, joint physician-pharmacist care to help them manage their
lipid levels doesn't have a significant impact, a new study finds. |
| You Can't Exercise Away TV's Toll on the Heart (HealthDay) |
| HealthDay - WEDNESDAY, March 3 (HealthDay News) -- People who watch more television
in their 20s and 30s are more apt to develop heart disease risk factors by
the time they reach their mid-40s than people who spent less time in front
of the screen, a new study finds. |
| Calcium and vitamin D may not cut cholesterol (Reuters) |
| Reuters - People looking to improve their heart health by lowering their cholesterol levels won't find help from calcium and vitamin D supplements, according to a new study. |
| Low-carb diet can increase bad cholesterol levels (Reuters) |
| Reuters - Cutting down on carbs may help people lose weight, but it may not be so good for lowering cholesterol, new research shows. |
| Diet changes improve older adults' cholesterol too (Reuters) |
| Reuters - Older adults can cut their cholesterol levels by revamping their dietary fat intake, even if they are already on cholesterol-lowering statins, a new study finds. |
| Crestor Approval Expanded For People Without High
Cholesterol (HealthDay) |
| HealthDay - TUESDAY, Feb. 9 (HealthDay News) -- U.S. Food and Drug
Administration approval for Crestor (rosuvastatin) has been widened to
include people who have no obvious symptoms of heart disease, Dow
Jones reported. |
|
